M. Suzanne Stratton

871 total citations
23 papers, 628 citations indexed

About

M. Suzanne Stratton is a scholar working on Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Nutrition and Dietetics. According to data from OpenAlex, M. Suzanne Stratton has authored 23 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Nutrition and Dietetics. Recurrent topics in M. Suzanne Stratton's work include Selenium in Biological Systems (7 papers), Hormonal and reproductive studies (7 papers) and Prostate Cancer Treatment and Research (6 papers). M. Suzanne Stratton is often cited by papers focused on Selenium in Biological Systems (7 papers), Hormonal and reproductive studies (7 papers) and Prostate Cancer Treatment and Research (6 papers). M. Suzanne Stratton collaborates with scholars based in United States, United Kingdom and New Zealand. M. Suzanne Stratton's co-authors include James R. Marshall, Raymond B. Nagle, Larry Clark, Mary E. Reid, Raj Natarajan, Marwan Fakih, David S. Alberts, Steven P. Stratton, Amit M. Algotar and Frederick R. Ahmann and has published in prestigious journals such as The American Journal of Medicine, Journal of Clinical Pathology and Cancer Epidemiology Biomarkers & Prevention.

In The Last Decade

M. Suzanne Stratton

23 papers receiving 609 citations

Peers

M. Suzanne Stratton
Irène Zbinden Switzerland
Glenda J. Moser United States
Carter J. Grandjean United States
Sangyong Choi United States
M. Suzanne Stratton
Citations per year, relative to M. Suzanne Stratton M. Suzanne Stratton (= 1×) peers Yasuaki Tatsumi

Countries citing papers authored by M. Suzanne Stratton

Since Specialization
Citations

This map shows the geographic impact of M. Suzanne Stratton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Suzanne Stratton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Suzanne Stratton more than expected).

Fields of papers citing papers by M. Suzanne Stratton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Suzanne Stratton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Suzanne Stratton. The network helps show where M. Suzanne Stratton may publish in the future.

Co-authorship network of co-authors of M. Suzanne Stratton

This figure shows the co-authorship network connecting the top 25 collaborators of M. Suzanne Stratton. A scholar is included among the top collaborators of M. Suzanne Stratton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Suzanne Stratton. M. Suzanne Stratton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Algotar, Amit M., et al.. (2014). Chronic Use of NSAIDs and/or Statins Does Not Affect PSA or PSA Velocity in Men at High Risk for Prostate Cancer. Cancer Epidemiology Biomarkers & Prevention. 23(10). 2196–2198. 6 indexed citations
2.
Algotar, Amit M., M. Suzanne Stratton, Frederick R. Ahmann, et al.. (2012). Phase 3 clinical trial investigating the effect of selenium supplementation in men at high‐risk for prostate cancer. The Prostate. 73(3). 328–335. 74 indexed citations
3.
Algotar, Amit M., Philip A. Thompson, James Ranger‐Moore, et al.. (2011). Differences in characteristics of men with localised prostate cancer who demonstrate low, intermediate or high prostate‐specific antigen velocity. Internal Medicine Journal. 42(4). 374–380. 2 indexed citations
4.
Algotar, Amit M., Patricia A. Thompson, James Ranger‐Moore, et al.. (2010). Effect of aspirin, other NSAIDs, and statins on PSA and PSA velocity. The Prostate. 70(8). 883–888. 20 indexed citations
5.
Stratton, M. Suzanne, Amit M. Algotar, James Ranger‐Moore, et al.. (2010). Oral Selenium Supplementation Has No Effect on Prostate-Specific Antigen Velocity in Men Undergoing Active Surveillance for Localized Prostate Cancer. Cancer Prevention Research. 3(8). 1035–1043. 37 indexed citations
6.
Algotar, Amit M., M. Suzanne Stratton, Steven P. Stratton, Chiu‐Hsieh Hsu, & Frederick R. Ahmann. (2010). No Effect of Selenium Supplementation on Serum Glucose Levels in Men with Prostate Cancer. The American Journal of Medicine. 123(8). 765–768. 16 indexed citations
7.
Jacobson, Elaine L., Hyun-Tae Kim, Joshua D. Williams, et al.. (2007). A topical lipophilic niacin derivative increases NAD, epidermal differentiation and barrier function in photodamaged skin. Experimental Dermatology. 16(6). 490–499. 45 indexed citations
8.
Stratton, Steven P., M. Suzanne Stratton, & David S. Alberts. (2006). Promising agents for chemoprevention of skin cancer.. PubMed. 13(5). 185–6. 2 indexed citations
9.
Reid, Mary E., M. Suzanne Stratton, Marwan Fakih, et al.. (2004). A report of high-dose selenium supplementation: response and toxicities. Journal of Trace Elements in Medicine and Biology. 18(1). 69–74. 162 indexed citations
10.
Nyman, David, M. Suzanne Stratton, Michael J. Kopplin, et al.. (2004). Selenium and selenomethionine levels in prostate cancer patients. Cancer Detection and Prevention. 28(1). 8–16. 44 indexed citations
12.
Stratton, M. Suzanne, et al.. (2003). Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy Study. Anti-Cancer Drugs. 14(8). 589–594. 35 indexed citations
13.
Thompson, Eric J., Ashok Gupta, M. Suzanne Stratton, & G. Tim Bowden. (2002). Mechanism of action of a dominant negative c‐jun mutant in inhibiting activator protein‐1 activation. Molecular Carcinogenesis. 35(4). 157–162. 18 indexed citations
14.
Stratton, M. Suzanne, et al.. (2002). Androgens block interleukin‐1β–induced promatrilysin expression in prostate carcinoma cells. The Prostate. 53(1). 1–8. 2 indexed citations
15.
Udayakumar, Thirupandiyur S., M. Suzanne Stratton, Raymond B. Nagle, & G. Timothy Bowden. (2002). Fibroblast Growth Factor-1 Induced Promatrilysin Expression Through the Activation of Extracellular-regulated Kinases and STAT3. Neoplasia. 4(1). 60–67. 39 indexed citations
16.
Stratton, M. Suzanne & David S. Alberts. (2002). Current application of selective COX-2 inhibitors in cancer prevention and treatment.. PubMed. 16(5 Suppl 4). 37–51. 21 indexed citations
17.
Bartels, Peter H., James Ranger‐Moore, M. Suzanne Stratton, et al.. (2002). Statistical analysis of chemopreventive efficacy of vitamin A in sun-exposed, normal skin.. PubMed. 24(4). 185–97. 6 indexed citations
18.
Stratton, M. Suzanne, et al.. (2001). Expression of the matrix metalloproteinase promatrilysin in coculture of prostate carcinoma cell lines. The Prostate. 48(3). 206–209. 7 indexed citations
19.
Hamid, Q., J. Rode, Adrienne M. Flanagan, et al.. (1988). Endocrine differentiation in inflamed urinary bladder epithelium with metaplastic changes. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 412(3). 267–272. 9 indexed citations
20.
Stratton, M. Suzanne, David J. Evans, & Irvin A. Lampert. (1986). Prostatic adenocarcinoma evolving into carcinoid: selective effect of hormonal treatment?. Journal of Clinical Pathology. 39(7). 750–756. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026